Newsroom
Evexia Diagnostics Partners with Genomind to Offer Cutting-Edge Pharmacogenetic Testing to Clinicians
Genomind’s new partnership with Evexia Diagnostics expands access to its pharmacogenetic testing, helping more clinicians personalize treatments and improve patient outcomes through genetic insights.
Genomind Launches First-of-Its-Kind Patient Report: Offering Patients an Easy-to-Understand View into Personalized Genetic Test Results
KING OF PRUSSIA, Pa.–(BUSINESSWIRE)–Genomind, a leader in medication management and personalized medicine through pharmacogenetics (PGx), is proud to announce the release of its innovative Patient
Shore Quality Partners Teams with Genomind to Help Prevent Adverse Prescription Drug Events
Integrated precision medication management platform empowers clinicians with genetic insights intended to reduce polypharmacy errors that cost thousands of lives and billions of dollars annually.
Genomind Pharmacogenetic Population Health Tool Highlighted in American Journal of Managed Care and 22nd Population Health Colloquium
Innovative approach addresses a huge and costly public health burden.
Genomind Completes Integration with Epic with support from Parkview Physicians Group
Parkview providers now able to order Genomind testing and view results within their Epic EHR system.
Cosán and Genomind Partner to Help Prevent Adverse Prescription Drug Events for Older Adults
Integrated precision medication management platform empowers clinicians with genetic insights intended to reduce polypharmacy errors that cost thousands of lives and billions of dollars annually.
David Nash MD to Join Genomind’s Scientific Advisory Board
Genomind®, a leading precision healthcare company named David Nash, MD, MBA of Jefferson Health the newest member of its Scientific Advisory Board (SAB).
